217 related articles for article (PubMed ID: 27765660)
1. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
Clarke N; McNamara D; Kearney PM; O'Morain CA; Shearer N; Sharp L
Prev Med; 2016 Dec; 93():198-203. PubMed ID: 27765660
[TBL] [Abstract][Full Text] [Related]
2. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.
van der Vlugt M; Grobbee EJ; Bossuyt PM; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Essink-Bot ML; Spaander MC; Dekker E
Br J Cancer; 2017 Jan; 116(1):44-49. PubMed ID: 27923037
[TBL] [Abstract][Full Text] [Related]
3. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
4. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
5. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
[TBL] [Abstract][Full Text] [Related]
6. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
[TBL] [Abstract][Full Text] [Related]
7. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
[TBL] [Abstract][Full Text] [Related]
8. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
9. Uptake trends in the Scottish Bowel Screening Programme and the influences of age, sex, and deprivation.
Quyn AJ; Fraser CG; Stanners G; Carey FA; Carden C; Shaukat A; Steele RJ
J Med Screen; 2018 Mar; 25(1):24-31. PubMed ID: 29183246
[TBL] [Abstract][Full Text] [Related]
10. Participation rates for organized colorectal cancer screening programmes: an international comparison.
Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
[TBL] [Abstract][Full Text] [Related]
11. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
[TBL] [Abstract][Full Text] [Related]
12. Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.
Denters MJ; Deutekom M; Bossuyt PM; van Rijn AF; Fockens P; Dekker E
Cancer Epidemiol; 2013 Jun; 37(3):330-5. PubMed ID: 23403127
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
14. Return to bowel screening after a false-positive faecal immunochemical test in BowelScreen (the National Bowel Screening Programme in Ireland).
Ch'ng BX; Mooney T; O'Donoghue D; Fitzpatrick P
J Med Screen; 2019 Dec; 26(4):186-190. PubMed ID: 31345130
[No Abstract] [Full Text] [Related]
15. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.
Knudsen MD; Berstad P; Hjartåker A; Gulichsen EH; Hoff G; de Lange T; Bernklev T; Botteri E
Br J Cancer; 2017 Aug; 117(4):461-469. PubMed ID: 28704841
[TBL] [Abstract][Full Text] [Related]
16. Initial participation as a predictor for continuous participation in population-based colorectal cancer screening.
Saraste D; Öhman DJ; Sventelius M; Elfström KM; Blom J; Törnberg S
J Med Screen; 2018 Sep; 25(3):126-133. PubMed ID: 28786766
[TBL] [Abstract][Full Text] [Related]
17. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening with faecal immunochemical test: Patterns of participation.
Heyman H; Blom J; Saraste D
J Med Screen; 2024 Mar; 31(1):15-20. PubMed ID: 37464838
[TBL] [Abstract][Full Text] [Related]
19. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
Osborne JM; Wilson C; Duncan A; Cole SR; Flight I; Turnbull D; Hughes DL; Young GP
BMC Public Health; 2017 Aug; 18(1):81. PubMed ID: 28764667
[TBL] [Abstract][Full Text] [Related]
20. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]